Viral Hepatitis, Type B: Studies on Natural History and Prevention Re-Examined

New England Journal of Medicine

Volumn 300, Issue 3, 1979, Pages 101-106

  Krugman, Saul ^a,b   Overby, Lacy R ^a,b   Mushahwar, Isa K ^a,b   Ling, Chung Mei ^a,b   Frösner, Gert G ^a,b   Deinhardt, Friedrich ^a,b  

^a NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^b ABBOTT LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIBODY; HEPATITIS B(E) ANTIBODY; HEPATITIS B(E) ANTIGEN;

HEPATITIS B VIRUS; LIVER; MAJOR CLINICAL STUDY; PREVENTION;

EID: 0018394957     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJM197901183000301     Document Type: Article

References (23)

1. Ward R, Krugman S, Giles JP, et al: Infectious hepatitis: studies of its natural history and prevention. N Engl J Med 258: 407–416, 1958
2. Krugman S, Giles JP, Hammond J: Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 200: 365–373, 1967
3. Giles JP, McCollum RW, Berndtson LW Jr, et al: Viral hepatitis: relation of Australia/SH antigen to the Willowbrook MS-2 strain. N Engl J Med 281: 119–122, 1969
4. Krugman S, Giles JP: Viral hepatitis: new light on an old disease. JAMA 212: 1019–1029, 1970
5. Krugman S, Giles JP, Hammond J: Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-1 and MS-2 strains. J Infect Dis 122: 432–436, 1970
6. Krugman: Viral hepatitis, type B (MS-2 strain): studies on active immunization. JAMA 217: 41–45, 1971
7. Krugman: Viral hepatitis, type B (MS-2 strain): prevention with specific hepatitis B immune serum globulin. JAMA 218: 1665–1670, 1971
8. Krugman S, Giles JP: Viral hepatitis type B (MS-2-strain): further observations on natural history and prevention. N Engl J Med 288: 755–760, 1973
9. Krugman S, Hoofnagle JH, Gerety RJ, et al: Viral hepatitis, type B: DNA polymerase activity and antibody to hepatitis B core antigen. N Engl J Med 290: 1331–1335, 1974
10. Blumberg BS, Alter HJ, Visnich S: A “new” antigen in leukemia sera. JAMA 191: 541–546, 1965
11. Blumberg BS, Gerstley BJS, Hungerford DA, et al: A serum antigen (Australia antigen) in Down's syndrome, leukemia, and hepatitis. Ann Intern Med 66: 924–931, 1967
12. Prince AM: An antigen detected in the blood during the incubation period of serum hepatitis. Proc Natl Acad Sci USA 60: 814–821, 1968
13. Ling CM, Overby LR: Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with l25I-antibody. J Immunol 109: 834–841, 1972
14. Vyas GN, Shulman NR: Hemagglutination assay for antigen and antibody associated with viral hepatitis. Science 170: 332–333, 1970
15. Karmen A: A note on the spectophotometric assay of glutamic-oxalacetic transaminase in human blood serum. J Clin Invest 34: 131–133, 1955
16. Overby LR, Ling CM: Radioimmune assay for anti-core as evidence of exposure to hepatitis B virus. Rush-Presbyterian St Lukes Med Bull 15: 83–92, 1976
17. Frösner GG, Brodersen M, Papaevangelou G, et al: Detection of HBeAg and anti-HBe in acute hepatitis by a sensitive radioimmunoassay. J Med Virol 3: 67–76, 1978
18. Mushahwar IK, Overby LR, Frosner G, et al: Prevalence of hepatitis B e antigen and its antibody as detected by radioimmunoassays. J Med Virol 2: 77–87, 1978
19. Hoofnagle JH, Gerety RJ, Barker LF: Antibody to hepatitis-B-virus core in man. Lancet 2: 869–873, 1973
20. Magnius LO, Espmark A: A new antigen complex co-occurring with Australia antigen. Acta Pathol Microbiol Scand 80 [B]: 335–337, 1972
21. Neefe JR, Gellis SS, Stokes J Jr: Homologous serum hepatitis and infectious (epidemic) hepatitis: studies in volunteers bearing on immunological and other characteristics of the etiological agents. Am J Med 1: 3–22, 1946
22. Redeker AG: Viral hepatitis: clinical aspects. Am J Med Sci 270: 9–16, 1975
23. Prince AM, Szmuness W, Woods KR, et al: Antibody against serum-hepatitis antigen: prevalence and potential use as immune serum globulin in prevention of serum-hepatitis infections. N Engl J Med 285: 933–938, 1971